European Phase III Study of APD421 in PONV

NCT01991821 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

PONV

Interventions

DRUG: APD421
DRUG: Placebo

Sponsor

Acacia Pharma Ltd